Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 600,411 | 559,734 | 467,451 | 472,224 | 488,735 |
Marketable Securities | 169,037 | 168,127 | 152,467 | 162,368 | 161,049 |
Receivables | 347,813 | 269,755 | 333,832 | 290,648 | 271,258 |
Inventories | 310,421 | 300,794 | 278,062 | 271,745 | 289,308 |
Income taxes - deferred | 110,950 | 98,243 | 90,717 | 89,602 | 90,181 |
TOTAL | $1,572,057 | $1,427,604 | $1,353,543 | $1,307,780 | $1,321,073 |
Non-Current Assets | |||||
PPE Net | 449,375 | 451,190 | 436,149 | 443,206 | 445,221 |
Investments And Advances | 63,348 | 62,482 | 54,359 | 42,507 | 42,061 |
Intangibles | 1,080,607 | 1,190,731 | 1,207,403 | 1,246,043 | 1,287,029 |
Other Non-Current Assets | 25,550 | 25,355 | 25,733 | 30,780 | 29,523 |
TOTAL | $1,618,880 | $1,729,758 | $1,723,644 | $1,762,536 | $1,803,834 |
Total Assets | $3,190,937 | $3,157,362 | $3,077,187 | $3,070,316 | $3,124,907 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 10,392 | 29,933 | N/A | N/A | N/A |
Accounts payable and accrued liabilities | 298,639 | 209,690 | 211,160 | 194,407 | 186,808 |
TOTAL | $381,108 | $306,649 | $245,670 | $246,535 | $240,142 |
Non-Current Liabilities | |||||
Long Term Debt | 574,013 | 573,947 | 587,935 | 587,864 | 587,794 |
Deferred Revenues | 8,182 | 4,108 | 5,721 | 5,721 | 4,024 |
aiOther Non-Current Liabilities | 1,772 | 2,052 | 2,504 | 4,748 | 3,895 |
TOTAL | $678,539 | $710,916 | $731,048 | $736,627 | $734,533 |
Total Liabilities | $1,059,647 | $1,017,565 | $976,718 | $983,162 | $974,675 |
Shareholders' Equity | |||||
Shares Outstanding, K | 102,219 | 111,410 | 111,030 | 110,815 | 104,230 |
Common Shares | 368 | 367 | 367 | 366 | 364 |
Retained earnings | 1,494,713 | 1,510,331 | 1,486,643 | 1,472,438 | 1,432,826 |
Other shareholders' equity | 7,195 | 8,025 | -10,160 | -5,509 | 6,634 |
TOTAL | $2,131,290 | $2,139,797 | $2,100,469 | $2,087,154 | $2,150,232 |
Total Liabilities And Equity | $3,190,937 | $3,157,362 | $3,077,187 | $3,070,316 | $3,124,907 |